Hornung RJ, et al. - The indications and use of angiotensin-converting enzyme-inhibitor (ACEI) therapy were appraised by the authors for the treatment of persistent microalbuminuria (MA) and/or hypertension (HTN) in adolescents with type 1 diabetes mellitus (T1DM). Findings revealed low rates of both MA and/or HTN. Clinical monitoring post-commencement of therapy appeared to be inconsistent in those who required treatment with ACEI. In response to this research, the development of local consensus guidelines was undertaken for the management of persistent MA in children and adolescents with diabetes mellitus.